Pharma CEO Martin Shkreli is easy to hate, but that doesn’t mean he’s wrong.Shkreli is infamous for jacking up the price of a 62-year-old drug by 5,000%, and then defending the move as the innevitable product of capitalism.
His company, Turing Pharmaceuticals, is small, and the drug, Daraprim, is rarely used. Nevertheless, the move grabbed national attention.